These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8861876)

  • 1. Factors affecting the results of a broth microdilution antifungal susceptibility testing in vitro.
    Buchta V; Otcenásek M
    Zentralbl Bakteriol; 1996 Mar; 283(3):375-90. PubMed ID: 8861876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method.
    Norris HA; Elewski BE; Ghannoum MA
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S9-13. PubMed ID: 10367910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables.
    Rambali B; Fernandez JA; Van Nuffel L; Woestenborghs F; Baert L; Massart DL; Odds FC
    J Antimicrob Chemother; 2001 Aug; 48(2):163-77. PubMed ID: 11481285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of five antifungal agents against pathogenic Exophiala species.
    Li D; Li R; Wang D; Ma S
    Chin Med J (Engl); 1999 Jun; 112(6):484-8. PubMed ID: 11601322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH and other effects on the antifungal activity of cilofungin (LY121019).
    McIntyre KA; Galgiani JN
    Antimicrob Agents Chemother; 1989 May; 33(5):731-5. PubMed ID: 2751286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current topics in mycology].
    Khan M; Plempel M; Wassilew SW
    Z Hautkr; 1989 Oct; 64(10):837-8, 841-2. PubMed ID: 2686240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading.
    Llop C; Sala J; Riba MD; Guarro J
    Mycopathologia; 1999; 148(1):25-31. PubMed ID: 11086482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colorimetric broth microdilution for antifungal susceptibility testing].
    Yamane N; Tosaka M; Okazawa Y
    Rinsho Byori; 1996 Jan; 44(1):67-75. PubMed ID: 8691643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
    Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testing.
    Messer SA; Pfaller MA
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):77-81. PubMed ID: 8882893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent.
    Uchida K; Nishiyama Y; Yamaguchi H
    J Infect Chemother; 2004 Aug; 10(4):216-9. PubMed ID: 15365862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of antifungal susceptibility testing and clinical relevance.
    Espinel-Ingroff A; Barchiesi F; Hazen KC; Martinez-Suarez JV; Scalise G
    Med Mycol; 1998; 36 Suppl 1():68-78. PubMed ID: 9988494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
    Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Testing the sensitivity of opportunistic agents of mycoses to antimycotic drugs in vitro].
    Otcenásek M; Buchta V
    Cesk Epidemiol Mikrobiol Imunol; 1993 Mar; 42(1):29-34. PubMed ID: 8485769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
    Yamaguchi H; Hiratani T; Plempel M
    Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatophytes growth curve and in vitro susceptibility test: a broth micro-titration method.
    Alió AB; Mendoza M; Zambrano EA; Díaz E; Cavallera E
    Med Mycol; 2005 Jun; 43(4):319-25. PubMed ID: 16110777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
    Pfaller MA; Barry AL
    Mycopathologia; 1995; 130(1):3-9. PubMed ID: 7666925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro studies of a new oral azole antimycotic, BAY N 7133.
    Yamaguchi H; Hiratani T; Plempel M
    J Antimicrob Chemother; 1983 Feb; 11(2):135-49. PubMed ID: 6300015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.